{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from sklearn.model_selection import train_test_split\n",
    "from sklearn.preprocessing import StandardScaler, LabelEncoder\n",
    "from imblearn.over_sampling import SMOTE\n",
    "import tensorflow as tf\n",
    "from tensorflow.keras import Sequential\n",
    "from tensorflow.keras.layers import Conv1D, Dense, Dropout, BatchNormalization, Flatten\n",
    "from tensorflow.keras.utils import to_categorical\n",
    "from sklearn.utils.class_weight import compute_class_weight\n",
    "from sklearn.metrics import classification_report, confusion_matrix\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "from tqdm import tqdm\n",
    "from tensorflow.keras.regularizers import l2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load all the processed datasets\n",
    "file_paths = {\n",
    "\"medications\": \"ProcessedData/processed_medications.csv\",\n",
    "\"observations\": \"ProcessedData/processed_observations.csv\",\n",
    "\"patients\": \"ProcessedData/processed_patients.csv\",\n",
    "\"allergies\": \"ProcessedData/processed_allergies.csv\",\n",
    "\"conditions\": \"ProcessedData/processed_conditions.csv\",\n",
    "\"immunizations\": \"ProcessedData/processed_immunizations.csv\",\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "def load_and_merge_data(file_paths):\n",
    "    # Read and standardize identifier columns to \"id\"\n",
    "    data_frames = {}\n",
    "    for key, path in file_paths.items():\n",
    "        df = pd.read_csv(path)\n",
    "        id_columns = [col for col in df.columns if \"PATIENT\" in col or \"Id\" in col or \"id\" in col]\n",
    "        if id_columns:\n",
    "            df.rename(columns={id_columns[0]: \"id\"}, inplace=True)\n",
    "        # Add source-specific suffixes to columns (except \"id\")\n",
    "        df.columns = [f\"{col}_{key}\" if col != \"id\" else \"id\" for col in df.columns]\n",
    "        data_frames[key] = df\n",
    "\n",
    "    # Print initial row counts\n",
    "    for key, df in data_frames.items():\n",
    "        print(f\"Rows in {key}: {len(df)}\")\n",
    "\n",
    "    # Merge all dataframes on the 'id' column\n",
    "    merged_data = data_frames[\"patients\"]\n",
    "    for key, df in data_frames.items():\n",
    "        if key != \"patients\":\n",
    "            merged_data = pd.merge(merged_data, df, on=\"id\", how=\"left\")\n",
    "\n",
    "    # Print final row count\n",
    "    print(f\"Rows in final merged dataset: {len(merged_data)}\")\n",
    "\n",
    "    # Remove unnecessary columns used for label creation\n",
    "    columns_to_remove = ['REASONDESCRIPTION_COVID-19_medications', 'Infectious disease care plan (record artifact)_careplans','Body temperature_observations', 'Oxygen saturation in Arterial blood_observations', 'Suspected COVID-19_conditions']\n",
    "    columns_in_data = [col for col in columns_to_remove if col in merged_data.columns]\n",
    "    if columns_in_data:\n",
    "        merged_data.drop(columns=columns_in_data, inplace=True)\n",
    "        print(f\"Removed columns: {columns_in_data}\")\n",
    "\n",
    "    print(merged_data.columns.tolist())\n",
    "    return merged_data\n",
    "\n",
    "def preprocess_data(data):\n",
    "    # Fill missing values\n",
    "    data.fillna(0, inplace=True)\n",
    "\n",
    "    # Normalize numerical columns\n",
    "    numerical_cols = data.select_dtypes(include=[np.number]).columns\n",
    "    scaler = StandardScaler()\n",
    "    data[numerical_cols] = scaler.fit_transform(data[numerical_cols])\n",
    "\n",
    "    # Encode categorical columns\n",
    "    categorical_cols = data.select_dtypes(include=['object', 'category']).columns\n",
    "    for col in categorical_cols:\n",
    "        # Convert all values to strings to handle mixed types\n",
    "        data[col] = data[col].astype(str)\n",
    "        encoder = LabelEncoder()\n",
    "        data[col] = encoder.fit_transform(data[col])\n",
    "\n",
    "    return data\n",
    "\n",
    "def extract_high_correlation_features(data, target_column, threshold=0.9):\n",
    "    # Select only numeric columns\n",
    "    numeric_data = data.select_dtypes(include=[np.number])\n",
    "    \n",
    "    # Calculate correlation matrix\n",
    "    correlation_matrix = numeric_data.corr()\n",
    "    \n",
    "    # Ensure the target column is in the numeric data\n",
    "    if target_column not in numeric_data.columns:\n",
    "        raise ValueError(f\"The target column '{target_column}' is not numeric or not present in the dataset.\")\n",
    "    \n",
    "    # Extract features with correlation above the threshold\n",
    "    high_corr_features = correlation_matrix[target_column][correlation_matrix[target_column] > threshold].index.tolist()\n",
    "    return high_corr_features\n",
    "\n",
    "\n",
    "def create_labels(data):\n",
    "    labels = []\n",
    "    for _, row in data.iterrows():\n",
    "        if row[\"DECEASED_patients\"] == 1:\n",
    "            if \"COVID-19_conditions\" in row and row[\"COVID-19_conditions\"] == 1:\n",
    "                labels.append(0)  # Had COVID, died\n",
    "            else:\n",
    "                labels.append(1)  # Didn't have COVID, died\n",
    "        else:\n",
    "            if \"COVID-19_conditions\" in row and row[\"COVID-19_conditions\"] == 1:\n",
    "                labels.append(3)  # Had COVID, lived\n",
    "            else:\n",
    "                labels.append(2)  # Didn't have COVID, lived\n",
    "    return np.array(labels)\n",
    "\n",
    "def build_cnn_model(input_shape, num_classes):\n",
    "    model = Sequential([\n",
    "        Conv1D(64, kernel_size=3, activation='relu', input_shape=input_shape, kernel_regularizer=l2(0.01)),\n",
    "        BatchNormalization(),\n",
    "        Dropout(0.3),\n",
    "        Conv1D(128, kernel_size=3, activation='relu', kernel_regularizer=l2(0.01)),\n",
    "        BatchNormalization(),\n",
    "        Dropout(0.3),\n",
    "        Flatten(),\n",
    "        Dense(128, activation='relu', kernel_regularizer=l2(0.01)),\n",
    "        Dropout(0.5),\n",
    "        Dense(num_classes, activation='softmax')\n",
    "    ])\n",
    "    model.compile(optimizer='adam', loss='categorical_crossentropy', metrics=['accuracy'])\n",
    "    return model\n",
    "\n",
    "def visualize_class_distribution(y_resampled):\n",
    "    plt.figure(figsize=(8, 6))\n",
    "    sns.countplot(x=y_resampled)\n",
    "    plt.title(\"Class Distribution After SMOTE\")\n",
    "    plt.xlabel(\"Class\")\n",
    "    plt.ylabel(\"Frequency\")\n",
    "    plt.show()\n",
    "\n",
    "\n",
    "def train_and_evaluate_model(merged_data):\n",
    "    # Generate labels before preprocessing\n",
    "    labels = create_labels(merged_data)\n",
    "\n",
    "    # Preprocess the data (excluding target columns)\n",
    "    processed_data = preprocess_data(merged_data)\n",
    "    processed_data.drop(columns=[\"DECEASED_patients\", \"COVID-19_conditions\"], inplace=True, errors='ignore')\n",
    "\n",
    "    # Apply SMOTE to balance the dataset with a progress bar\n",
    "    smote = SMOTE(random_state=42)\n",
    "    with tqdm(total=1, desc=\"Applying SMOTE\") as pbar:\n",
    "        X_resampled, y_resampled = smote.fit_resample(processed_data, labels)\n",
    "        pbar.update(1)\n",
    "\n",
    "    # Visualize the class distribution after SMOTE\n",
    "    visualize_class_distribution(y_resampled)\n",
    "\n",
    "    # Train-test split\n",
    "    X_train, X_test, y_train, y_test = train_test_split(X_resampled, y_resampled, test_size=0.2, random_state=42)\n",
    "    y_train, y_test = to_categorical(y_train), to_categorical(y_test)\n",
    "\n",
    "    # Compute class weights\n",
    "    class_weights = compute_class_weight('balanced', classes=np.unique(y_resampled), y=y_resampled)\n",
    "    class_weight_dict = dict(enumerate(class_weights))\n",
    "\n",
    "    # Build the CNN model\n",
    "    input_shape = (X_train.shape[1], 1)\n",
    "    model = build_cnn_model(input_shape, y_train.shape[1])\n",
    "\n",
    "    # Train the model with class weights\n",
    "    model.fit(X_train.values[..., np.newaxis], y_train, epochs=3, batch_size=32, validation_split=0.2, class_weight=class_weight_dict)\n",
    "\n",
    "    # Evaluate the model\n",
    "    loss, accuracy = model.evaluate(X_test.values[..., np.newaxis], y_test)\n",
    "    print(f\"Test Loss: {loss}, Test Accuracy: {accuracy}\")\n",
    "\n",
    "    # Predictions\n",
    "    predictions = model.predict(X_test.values[..., np.newaxis])\n",
    "    predicted_classes = np.argmax(predictions, axis=1)\n",
    "    true_classes = np.argmax(y_test, axis=1)\n",
    "\n",
    "    # Classification report\n",
    "    print(\"Classification Report:\")\n",
    "    print(classification_report(true_classes, predicted_classes))\n",
    "\n",
    "    # Confusion matrix\n",
    "    conf_matrix = confusion_matrix(true_classes, predicted_classes)\n",
    "    plt.figure(figsize=(10, 8))\n",
    "    sns.heatmap(conf_matrix, annot=True, fmt='d', cmap='Blues', xticklabels=[\"COVID+Died\", \"NoCOVID+Died\", \"NoCOVID+Lived\", \"COVID+Lived\"],\n",
    "                yticklabels=[\"COVID+Died\", \"NoCOVID+Died\", \"NoCOVID+Lived\", \"COVID+Lived\"])\n",
    "    plt.title(\"Confusion Matrix\")\n",
    "    plt.ylabel(\"True Label\")\n",
    "    plt.xlabel(\"Predicted Label\")\n",
    "    plt.show()\n",
    "\n",
    "    # Evaluate the model on original (unbalanced) test data\n",
    "    X_train_orig, X_test_orig, y_train_orig, y_test_orig = train_test_split(\n",
    "        processed_data, labels, test_size=0.2, random_state=42\n",
    "    )\n",
    "    predictions_orig = model.predict(X_test_orig.values[..., np.newaxis])\n",
    "    predicted_classes_orig = np.argmax(predictions_orig, axis=1)\n",
    "    print(\"Original Test Set Classification Report:\")\n",
    "    print(classification_report(y_test_orig, predicted_classes_orig))\n",
    "\n",
    "    return model\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\sagor\\AppData\\Local\\Temp\\ipykernel_27320\\3319603043.py:5: DtypeWarning: Columns (3,13,57,70,84,132,162,181) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  df = pd.read_csv(path)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rows in medications: 9566\n",
      "Rows in observations: 12352\n",
      "Rows in patients: 12352\n",
      "Rows in allergies: 1528\n",
      "Rows in conditions: 12165\n",
      "Rows in immunizations: 10376\n",
      "Rows in final merged dataset: 12352\n",
      "Removed columns: ['REASONDESCRIPTION_COVID-19_medications']\n",
      "['id', 'FIRST_patients', 'LAST_patients', 'MAIDEN_patients', 'MARITAL_patients', 'RACE_patients', 'ETHNICITY_patients', 'GENDER_patients', 'BIRTHPLACE_patients', 'AGE_patients', 'DECEASED_patients', 'DESCRIPTION_0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe_medications', 'DESCRIPTION_0.3 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe_medications', 'DESCRIPTION_0.4 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe_medications', 'DESCRIPTION_0.67 ML anakinra 149 MG/ML Prefilled Syringe_medications', 'DESCRIPTION_1 ML DOCEtaxel 20 MG/ML Injection_medications', 'DESCRIPTION_1 ML Enoxaparin sodium 150 MG/ML Prefilled Syringe_medications', 'DESCRIPTION_1 ML Epinephrine 1 MG/ML Injection_medications', 'DESCRIPTION_1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]_medications', 'DESCRIPTION_1 ML Morphine Sulfate 5 MG/ML Injection_medications', 'DESCRIPTION_1 ML Vasopressin (USP) 20 UNT/ML Injection_medications', 'DESCRIPTION_1 ML denosumab 60 MG/ML Prefilled Syringe_medications', 'DESCRIPTION_1 ML heparin sodium  porcine 5000 UNT/ML Injection_medications', 'DESCRIPTION_1 ML medroxyPROGESTERone acetate 150 MG/ML Injection_medications', 'DESCRIPTION_1 ML medroxyprogesterone acetate 150 MG/ML Injection_medications', 'DESCRIPTION_10 ML Doxorubicin Hydrochloride 2 MG/ML Injection_medications', 'DESCRIPTION_10 ML Fentanyl 0.05 MG/ML Injection_medications', 'DESCRIPTION_10 ML Furosemide 10 MG/ML Injection_medications', 'DESCRIPTION_10 ML Pamidronate Disodium 3 MG/ML Injection_medications', 'DESCRIPTION_10 ML oxaliplatin 5 MG/ML Injection_medications', 'DESCRIPTION_100 ML Epirubicin Hydrochloride 2 MG/ML Injection_medications', 'DESCRIPTION_100 ML Propofol 10 MG/ML Injection_medications', 'DESCRIPTION_100 ML zoledronic acid 0.04 MG/ML Injection_medications', 'DESCRIPTION_12 HR Cefaclor 500 MG Extended Release Oral Tablet_medications', 'DESCRIPTION_120 ACTUAT Fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler_medications', 'DESCRIPTION_168 HR Ethinyl Estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System_medications', 'DESCRIPTION_2 ML Ondansetron 2 MG/ML Injection_medications', 'DESCRIPTION_20 ML tocilizumab 20 MG/ML Injection_medications', 'DESCRIPTION_24 HR Donepezil hydrochloride 10 MG / Memantine hydrochloride 28 MG Extended Release Oral Capsule_medications', 'DESCRIPTION_24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet_medications', 'DESCRIPTION_24 HR metoprolol succinate 100 MG Extended Release Oral Tablet [Toprol]_medications', 'DESCRIPTION_24hr nicotine transdermal patch_medications', 'DESCRIPTION_3 ML Amiodarone hydrocholoride 50 MG/ML Prefilled Syringe_medications', 'DESCRIPTION_3 ML liraglutide 6 MG/ML Pen Injector_medications', 'DESCRIPTION_4 ML Norepinephrine 1 MG/ML Injection_medications', 'DESCRIPTION_5 ML fulvestrant 50 MG/ML Prefilled Syringe_medications', 'DESCRIPTION_5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab 120 MG/ML Injection_medications', 'DESCRIPTION_60 ACTUAT Fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler_medications', 'DESCRIPTION_Abuse-Deterrent 12 HR Oxycodone Hydrochloride 15 MG Extended Release Oral Tablet_medications', 'DESCRIPTION_Acetaminophen 160 MG Chewable Tablet_medications', 'DESCRIPTION_Acetaminophen 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution_medications', 'DESCRIPTION_Acetaminophen 300 MG / HYDROcodone Bitartrate 5 MG Oral Tablet_medications', 'DESCRIPTION_Acetaminophen 325 MG / HYDROcodone Bitartrate 7.5 MG Oral Tablet_medications', 'DESCRIPTION_Acetaminophen 325 MG / Oxycodone Hydrochloride 5 MG Oral Tablet_medications', 'DESCRIPTION_Acetaminophen 325 MG / oxyCODONE Hydrochloride 2.5 MG Oral Tablet_medications', 'DESCRIPTION_Acetaminophen 325 MG / oxyCODONE Hydrochloride 5 MG Oral Tablet_medications', 'DESCRIPTION_Acetaminophen 325 MG Oral Tablet_medications', 'DESCRIPTION_Acetaminophen 500 MG Oral Tablet_medications', 'DESCRIPTION_Acetaminophen/Hydrocodone_medications', 'DESCRIPTION_Albuterol 5 MG/ML Inhalation Solution_medications', 'DESCRIPTION_Alendronic acid 10 MG Oral Tablet_medications', 'DESCRIPTION_Allopurinol 100 MG Oral Tablet_medications', 'DESCRIPTION_Alteplase 100 MG Injection_medications', 'DESCRIPTION_Amlodipine 5 MG Oral Tablet_medications', 'DESCRIPTION_Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet_medications', 'DESCRIPTION_Amoxicillin 250 MG Oral Capsule_medications', 'DESCRIPTION_Amoxicillin 500 MG Oral Tablet_medications', 'DESCRIPTION_Aspirin 81 MG Oral Tablet_medications', 'DESCRIPTION_Astemizole 10 MG Oral Tablet_medications', 'DESCRIPTION_Atenolol 50 MG / Chlorthalidone 25 MG Oral Tablet_medications', 'DESCRIPTION_Atorvastatin 80 MG Oral Tablet_medications', 'DESCRIPTION_Atropine Sulfate 1 MG/ML Injectable Solution_medications', 'DESCRIPTION_Aviptadil Infusion_medications', 'DESCRIPTION_Azithromycin 250 MG Oral Tablet_medications', 'DESCRIPTION_CD24Fc 480 MG IV_medications', 'DESCRIPTION_CM4620 Injectable Emulsion_medications', 'DESCRIPTION_Camila 28 Day Pack_medications', 'DESCRIPTION_Captopril 25 MG Oral Tablet_medications', 'DESCRIPTION_Carbamazepine[Tegretol]_medications', 'DESCRIPTION_Carboplatin 10 MG/ML Injectable Solution_medications', 'DESCRIPTION_Cefaclor 250 MG Oral Capsule_medications', 'DESCRIPTION_Cefuroxime 250 MG Oral Tablet_medications', 'DESCRIPTION_Chlorpheniramine Maleate 2 MG/ML Oral Solution_medications', 'DESCRIPTION_Chlorpheniramine Maleate 4 MG Oral Tablet_medications', 'DESCRIPTION_Cisplatin 50 MG Injection_medications', 'DESCRIPTION_Clopidogrel 75 MG Oral Tablet_medications', 'DESCRIPTION_Colchicine 0.6 MG Oral Tablet_medications', 'DESCRIPTION_Cyclophosphamide 1000 MG Injection_medications', 'DESCRIPTION_Diazepam 5 MG Oral Tablet_medications', 'DESCRIPTION_Digoxin 0.125 MG Oral Tablet_medications', 'DESCRIPTION_Donepezil hydrochloride 10 MG Oral Tablet_medications', 'DESCRIPTION_Donepezil hydrochloride 23 MG Oral Tablet_medications', 'DESCRIPTION_Doxycycline Monohydrate 100 MG Oral Tablet_medications', 'DESCRIPTION_Doxycycline Monohydrate 50 MG Oral Tablet_medications', 'DESCRIPTION_Errin 28 Day Pack_medications', 'DESCRIPTION_Estrostep Fe 28 Day Pack_medications', 'DESCRIPTION_Etonogestrel 68 MG Drug Implant_medications', 'DESCRIPTION_Etoposide 100 MG Injection_medications', 'DESCRIPTION_FLUoxetine 20 MG Oral Capsule_medications', 'DESCRIPTION_Fexofenadine hydrochloride 30 MG Oral Tablet_medications', 'DESCRIPTION_Fexofenadine hydrochloride 60 MG Oral Tablet_medications', 'DESCRIPTION_Furosemide 40 MG Oral Tablet_medications', 'DESCRIPTION_Galantamine 4 MG Oral Tablet_medications', 'DESCRIPTION_Hydrochlorothiazide 12.5 MG_medications', 'DESCRIPTION_Hydrochlorothiazide 25 MG Oral Tablet_medications', 'DESCRIPTION_Hydrocortisone 10 MG/ML Topical Cream_medications', 'DESCRIPTION_Hydroxychloroquine Sulfate 200 MG Oral Tablet_medications', 'DESCRIPTION_Ibuprofen 100 MG Oral Tablet_medications', 'DESCRIPTION_Ibuprofen 200 MG Oral Tablet_medications', 'DESCRIPTION_Insulin Lispro 100 UNT/ML Injectable Solution [Humalog]_medications', 'DESCRIPTION_Isoflurane 999 MG/ML Inhalant Solution_medications', 'DESCRIPTION_Jolivette 28 Day Pack_medications', 'DESCRIPTION_Kyleena 19.5 MG Intrauterine System_medications', 'DESCRIPTION_Lenzilumab 200 MG IV_medications', 'DESCRIPTION_Leronlimab 700 MG Injection_medications', 'DESCRIPTION_Leucovorin 100 MG Injection_medications', 'DESCRIPTION_Levora 0.15/30 28 Day Pack_medications', 'DESCRIPTION_Levothyroxine Sodium 0.075 MG Oral Tablet_medications', 'DESCRIPTION_Liletta 52 MG Intrauterine System_medications', 'DESCRIPTION_Loratadine 10 MG Oral Tablet_medications', 'DESCRIPTION_Loratadine 5 MG Chewable Tablet_medications', 'DESCRIPTION_Memantine hydrochloride 2 MG/ML Oral Solution_medications', 'DESCRIPTION_Meperidine Hydrochloride 50 MG Oral Tablet_medications', 'DESCRIPTION_Mestranol / Norethynodrel [Enovid]_medications', 'DESCRIPTION_Methotrexate 2.5 MG Oral Tablet_medications', 'DESCRIPTION_Methylphenidate Hydrochloride 20 MG Oral Tablet_medications', 'DESCRIPTION_Midazolam 1 MG/ML Injectable Solution_medications', 'DESCRIPTION_Milnacipran hydrochloride 100 MG Oral Tablet_medications', 'DESCRIPTION_Mirena 52 MG Intrauterine System_medications', 'DESCRIPTION_NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler_medications', 'DESCRIPTION_NDA020800 0.3 ML Epinephrine 1 MG/ML Auto-Injector_medications', 'DESCRIPTION_NITROFURANTOIN  MACROCRYSTALS 50 MG Oral Capsule_medications', 'DESCRIPTION_Naproxen 500 MG Oral Tablet_medications', 'DESCRIPTION_Naproxen sodium 220 MG Oral Tablet_medications', 'DESCRIPTION_Natazia 28 Day Pack_medications', 'DESCRIPTION_Nitrofurantoin 5 MG/ML Oral Suspension_medications', 'DESCRIPTION_Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray_medications', 'DESCRIPTION_Norinyl 1+50 28 Day Pack_medications', 'DESCRIPTION_NuvaRing 0.12/0.015 MG per 24HR 21 Day Vaginal Ring_medications', 'DESCRIPTION_Ortho Tri-Cyclen 28 Day Pack_medications', 'DESCRIPTION_PACLitaxel 100 MG Injection_medications', 'DESCRIPTION_Paclitaxel 100 MG Injection_medications', 'DESCRIPTION_Pancreatin 600 MG Oral Tablet_medications', 'DESCRIPTION_Penicillin G 375 MG/ML Injectable Solution_medications', 'DESCRIPTION_Penicillin V Potassium 250 MG Oral Tablet_medications', 'DESCRIPTION_Penicillin V Potassium 500 MG Oral Tablet_medications', 'DESCRIPTION_Phenazopyridine hydrochloride 100 MG Oral Tablet_medications', 'DESCRIPTION_Piperacillin 4000 MG / tazobactam 500 MG Injection_medications', 'DESCRIPTION_Pulmozyme (Dornase Alfa)_medications', 'DESCRIPTION_Rocuronium bromide 10 MG/ML Injectable Solution_medications', 'DESCRIPTION_Seasonique 91 Day Pack_medications', 'DESCRIPTION_Sertraline 100 MG Oral Tablet_medications', 'DESCRIPTION_Simvastatin 10 MG Oral Tablet_medications', 'DESCRIPTION_Simvastatin 20 MG Oral Tablet_medications', 'DESCRIPTION_Sodium Chloride 9 MG/ML Injectable Solution_medications', 'DESCRIPTION_Tacrine 10 MG Oral Capsule_medications', 'DESCRIPTION_Tamoxifen 10 MG Oral Tablet_medications', 'DESCRIPTION_Terfenadine 60 MG Oral Tablet_medications', 'DESCRIPTION_Trinessa 28 Day Pack_medications', 'DESCRIPTION_Verapamil Hydrochloride 40 MG_medications', 'DESCRIPTION_Verzenio 100 MG Oral Tablet_medications', 'DESCRIPTION_Vitamin B 12 5 MG/ML Injectable Solution_medications', 'DESCRIPTION_Warfarin Sodium 5 MG Oral Tablet_medications', 'DESCRIPTION_Yaz 28 Day Pack_medications', 'DESCRIPTION_amLODIPine 5 MG / Hydrochlorothiazide 12.5 MG / Olmesartan medoxomil 20 MG Oral Tablet_medications', 'DESCRIPTION_anastrozole 1 MG Oral Tablet_medications', 'DESCRIPTION_atomoxetine 100 MG Oral Capsule_medications', 'DESCRIPTION_baricitinib 2 MG Oral Tablet_medications', 'DESCRIPTION_cetirizine hydrochloride 10 MG Oral Tablet_medications', 'DESCRIPTION_cetirizine hydrochloride 5 MG Oral Tablet_medications', 'DESCRIPTION_chloroquine phosphate 500 MG Oral Tablet_medications', 'DESCRIPTION_clonazePAM 0.25 MG Oral Tablet_medications', 'DESCRIPTION_cycloSPORINE  modified 100 MG Oral Capsule_medications', 'DESCRIPTION_desflurane 1000 MG/ML Inhalation Solution_medications', 'DESCRIPTION_diphenhydrAMINE Hydrochloride 25 MG Oral Tablet_medications', 'DESCRIPTION_duloxetine 20 MG Delayed Release Oral Capsule_medications', 'DESCRIPTION_ferrous sulfate 325 MG Oral Tablet_medications', 'DESCRIPTION_insulin human  isophane 70 UNT/ML / Regular Insulin  Human 30 UNT/ML Injectable Suspension [Humulin]_medications', 'DESCRIPTION_letrozole 2.5 MG Oral Tablet_medications', 'DESCRIPTION_palbociclib 100 MG Oral Capsule_medications', 'DESCRIPTION_piperacillin 4000 MG / tazobactam 500 MG Injection_medications', 'DESCRIPTION_predniSONE 5 MG Oral Tablet_medications', 'DESCRIPTION_pregabalin 100 MG Oral Capsule_medications', 'DESCRIPTION_remdesivir 100 MG Injection_medications', 'DESCRIPTION_remifentanil 2 MG Injection_medications', 'DESCRIPTION_ribociclib 200 MG Oral Tablet_medications', 'DESCRIPTION_vancomycin 1000 MG Injection_medications', 'REASONDESCRIPTION_Acute bacterial sinusitis (disorder)_medications', 'REASONDESCRIPTION_Acute bronchitis (disorder)_medications', 'REASONDESCRIPTION_Acute deep venous thrombosis (disorder)_medications', 'REASONDESCRIPTION_Acute pulmonary embolism (disorder)_medications', 'REASONDESCRIPTION_Acute viral pharyngitis (disorder)_medications', \"REASONDESCRIPTION_Alzheimer's disease (disorder)_medications\", 'REASONDESCRIPTION_Anemia (disorder)_medications', 'REASONDESCRIPTION_Asthma_medications', 'REASONDESCRIPTION_Atopic dermatitis_medications', 'REASONDESCRIPTION_Bacterial infectious disease (disorder)_medications', 'REASONDESCRIPTION_Child attention deficit disorder_medications', 'REASONDESCRIPTION_Childhood asthma_medications', 'REASONDESCRIPTION_Chronic congestive heart failure (disorder)_medications', 'REASONDESCRIPTION_Chronic obstructive bronchitis (disorder)_medications', 'REASONDESCRIPTION_Contact dermatitis_medications', 'REASONDESCRIPTION_Cystic Fibrosis_medications', 'REASONDESCRIPTION_Cystitis_medications', 'REASONDESCRIPTION_Diabetes_medications', 'REASONDESCRIPTION_Escherichia coli urinary tract infection_medications', \"REASONDESCRIPTION_Familial Alzheimer's disease of early onset (disorder)_medications\", 'REASONDESCRIPTION_Gout_medications', 'REASONDESCRIPTION_Hyperlipidemia_medications', 'REASONDESCRIPTION_Hypertension_medications', 'REASONDESCRIPTION_Hypoxemia (disorder)_medications', 'REASONDESCRIPTION_Localized  primary osteoarthritis of the hand_medications', 'REASONDESCRIPTION_Major depression  single episode_medications', 'REASONDESCRIPTION_Malignant neoplasm of breast (disorder)_medications', 'REASONDESCRIPTION_Malignant tumor of colon_medications', 'REASONDESCRIPTION_Non-small cell carcinoma of lung  TNM stage 1 (disorder)_medications', 'REASONDESCRIPTION_Osteoarthritis of hip_medications', 'REASONDESCRIPTION_Osteoarthritis of knee_medications', 'REASONDESCRIPTION_Overlapping malignant neoplasm of colon_medications', 'REASONDESCRIPTION_Posttraumatic stress disorder_medications', 'REASONDESCRIPTION_Primary fibromyalgia syndrome_medications', 'REASONDESCRIPTION_Primary small cell malignant neoplasm of lung  TNM stage 1 (disorder)_medications', 'REASONDESCRIPTION_Pulmonary emphysema (disorder)_medications', 'REASONDESCRIPTION_Rheumatoid arthritis_medications', 'REASONDESCRIPTION_Secondary malignant neoplasm of colon_medications', 'REASONDESCRIPTION_Septic shock (disorder)_medications', 'REASONDESCRIPTION_Sinusitis (disorder)_medications', 'REASONDESCRIPTION_Streptococcal sore throat (disorder)_medications', 'REASONDESCRIPTION_Viral sinusitis (disorder)_medications', 'ALT (Elevated)_observations', 'AST (Elevated)_observations', 'Abuse Status [OMAHA]_observations', 'Adenovirus A+B+C+D+E DNA [Presence] in Respiratory specimen by NAA with probe detection_observations', 'Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma_observations', 'Albumin_observations', 'Albumin [Mass/volume] in Serum or Plasma_observations', 'Alkaline Phosphatase_observations', 'Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma_observations', 'American house dust mite IgE Ab in Serum_observations', 'Anion Gap_observations', 'Appearance of Urine_observations', 'Are you covered by health insurance or some other kind of health care plan [PhenX]_observations', 'Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma_observations', 'Basophils [#/volume] in Blood by Automated count_observations', 'Basophils/100 leukocytes in Blood by Automated count_observations', 'Bicarbonate [Moles/volume] in Arterial blood_observations', 'Bilirubin.total [Mass/volume] in Serum or Plasma_observations', 'Bilirubin.total [Mass/volume] in Urine by Test strip_observations', 'Bilirubin.total [Presence] in Urine by Test strip_observations', 'Body Height_observations', 'Body Mass Index_observations', 'Body Weight_observations', 'Body mass index (BMI) [Percentile] Per age and gender_observations', 'Body temperature_observations', 'C reactive protein [Mass/volume] in Serum or Plasma_observations', 'Calcium_observations', 'Calcium [Mass/volume] in Serum or Plasma_observations', 'Carbon Dioxide_observations', 'Carbon dioxide  total [Moles/volume] in Serum or Plasma_observations', 'Carbon dioxide [Partial pressure] in Arterial blood_observations', 'Cat dander IgE Ab in Serum_observations', 'Cause of Death [US Standard Certificate of Death]_observations', 'Chloride_observations', 'Chloride [Moles/volume] in Serum or Plasma_observations', 'Cladosporium herbarum IgE Ab in Serum_observations', 'Clarity of Urine_observations', 'Codfish IgE Ab in Serum_observations', 'Color of Urine_observations', 'Common Ragweed IgE Ab in Serum_observations', 'Cow milk IgE Ab in Serum_observations', 'Creatine kinase [Enzymatic activity/volume] in Serum or Plasma_observations', 'Creatinine_observations', 'Creatinine [Mass/volume] in Serum or Plasma_observations', 'DALY_observations', 'DXA [T-score] Bone density_observations', 'Diastolic Blood Pressure_observations', 'Distant metastases.clinical [Class] Cancer_observations', 'Egg white IgE Ab in Serum_observations', 'Eosinophils [#/volume] in Blood by Automated count_observations', 'Eosinophils/100 leukocytes in Blood by Automated count_observations', 'Erythrocyte distribution width [Entitic volume] by Automated count_observations', 'Erythrocyte distribution width [Ratio] by Automated count_observations', 'Erythrocytes [#/volume] in Blood by Automated count_observations', 'Estimated Glomerular Filtration Rate_observations', 'Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain_observations', 'Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain_observations', 'FEV1/FVC_observations', 'Ferritin [Mass/volume] in Serum or Plasma_observations', 'Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma_observations', 'Globulin_observations', 'Globulin [Mass/volume] in Serum by calculation_observations', 'Glomerular filtration rate/1.73 sq M.predicted_observations', 'Glucose_observations', 'Glucose [Mass/volume] in Serum or Plasma_observations', 'Glucose [Mass/volume] in Urine by Test strip_observations', 'Glucose [Presence] in Urine by Test strip_observations', 'HER2 [Presence] in Breast cancer specimen by FISH_observations', 'HER2 [Presence] in Breast cancer specimen by Immune stain_observations', 'HIV status_observations', 'Head Occipital-frontal circumference_observations', 'Heart rate_observations', 'Hematocrit_observations', 'Hematocrit [Volume Fraction] of Blood_observations', 'Hematocrit [Volume Fraction] of Blood by Automated count_observations', 'Hemoglobin_observations', 'Hemoglobin A1c/Hemoglobin.total in Blood_observations', 'Hemoglobin [Mass/volume] in Blood_observations', 'Hemoglobin [Presence] in Urine by Test strip_observations', 'Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method_observations', 'High Density Lipoprotein Cholesterol_observations', 'History of Hospitalizations+Outpatient visits_observations', 'Honey bee IgE Ab in Serum_observations', 'Housing status_observations', 'Human metapneumovirus RNA [Presence] in Respiratory specimen by NAA with probe detection_observations', 'INR in Platelet poor plasma by Coagulation assay_observations', 'Influenza virus A Ag [Presence] in Nasopharynx by Rapid immunoassay_observations', 'Influenza virus A RNA [Presence] in Respiratory specimen by NAA with probe detection_observations', 'Influenza virus B Ag [Presence] in Nasopharynx by Rapid immunoassay_observations', 'Influenza virus B RNA [Presence] in Respiratory specimen by NAA with probe detection_observations', 'Interleukin 6 [Mass/volume] in Serum or Plasma_observations', 'Ketones [Mass/volume] in Urine by Test strip_observations', 'Ketones [Presence] in Urine by Test strip_observations', 'Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction_observations', 'Latex IgE Ab in Serum_observations', 'Left ventricular Ejection fraction_observations', 'Leukocyte esterase [Presence] in Urine by Test strip_observations', 'Leukocytes [#/volume] in Blood by Automated count_observations', 'Low Density Lipoprotein Cholesterol_observations', 'Lymph nodes with isolated tumor cells [#] in Cancer specimen by Light microscopy_observations', 'Lymph nodes with micrometastases [#] in Cancer specimen by Light microscopy_observations', 'Lymphocytes [#/volume] in Blood by Automated count_observations', 'Lymphocytes/100 leukocytes in Blood by Automated count_observations', 'MCH [Entitic mass] by Automated count_observations', 'MCHC [Mass/volume] by Automated count_observations', 'MCV_observations', 'MCV [Entitic volume] by Automated count_observations', 'Mental health Outpatient Note_observations', 'Mental health Telehealth Note_observations', 'Microalbumin Creatinine Ratio_observations', 'Monocytes [#/volume] in Blood by Automated count_observations', 'Monocytes/100 leukocytes in Blood by Automated count_observations', 'NT-proBNP_observations', 'Neutrophils [#/volume] in Blood by Automated count_observations', 'Neutrophils/100 leukocytes in Blood by Automated count_observations', 'Nitrite [Presence] in Urine by Test strip_observations', 'Odor of Urine_observations', 'Oxygen [Partial pressure] in Arterial blood_observations', 'Oxygen saturation in Arterial blood_observations', 'Oxygen/Inspired gas setting [Volume Fraction] Ventilator_observations', 'PROMIS-10 Global Mental Health (GMH) score_observations', 'PROMIS-10 Global Physical Health (GPH) score_observations', 'Pain severity - 0-10 verbal numeric rating [Score] - Reported_observations', 'Parainfluenza virus 1 RNA [Presence] in Respiratory specimen by NAA with probe detection_observations', 'Parainfluenza virus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection_observations', 'Parainfluenza virus 3 RNA [Presence] in Respiratory specimen by NAA with probe detection_observations', 'Peanut IgE Ab in Serum_observations', 'Percentage area affected by eczema Head and Neck_observations', 'Percentage area affected by eczema Lower extremitiy - bilateral_observations', 'Percentage area affected by eczema Trunk_observations', 'Percentage area affected by eczema Upper extremitiy - bilateral_observations', 'Physical findings of Abdomen by Palpation_observations', 'Physical findings of Prostate_observations', 'Platelet Count_observations', 'Platelet distribution width [Entitic volume] in Blood by Automated count_observations', 'Platelet mean volume [Entitic volume] in Blood by Automated count_observations', 'Platelets [#/volume] in Blood by Automated count_observations', 'Polyp size greatest dimension by CAP cancer protocols_observations', 'Potassium_observations', 'Potassium [Moles/volume] in Serum or Plasma_observations', 'Primary tumor.clinical [Class] Cancer_observations', 'Procalcitonin [Mass/volume] in Serum or Plasma_observations', 'Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain_observations', 'Prostate specific Ag [Mass/volume] in Serum or Plasma_observations', 'Protein_observations', 'Protein [Mass/volume] in Serum or Plasma_observations', 'Protein [Mass/volume] in Urine by Test strip_observations', 'Protein [Presence] in Urine by Test strip_observations', 'Prothrombin time (PT)_observations', 'QALY_observations', 'QOLS_observations', 'RBC Auto (Bld) [#/Vol]_observations', 'RBC Distribution Width_observations', 'RDW - Erythrocyte distribution width Auto (RBC) [Entitic vol]_observations', 'Red Blood Cell_observations', 'Regional lymph nodes.clinical [Class] Cancer_observations', 'Respiratory rate_observations', 'Respiratory syncytial virus RNA [Presence] in Respiratory specimen by NAA with probe detection_observations', 'Response to cancer treatment_observations', 'Rhinovirus RNA [Presence] in Respiratory specimen by NAA with probe detection_observations', 'SARS-CoV-2 RNA Pnl Resp NAA+probe_observations', 'Sexual orientation_observations', 'Shrimp IgE Ab in Serum_observations', 'Site of distant metastasis in Breast tumor_observations', 'Size.maximum dimension in Tumor_observations', 'Sodium_observations', 'Sodium [Moles/volume] in Serum or Plasma_observations', 'Soybean IgE Ab in Serum_observations', 'Specific gravity of Urine by Test strip_observations', 'Stage group.clinical Cancer_observations', 'Systolic Blood Pressure_observations', 'Thyrotropin [Units/volume] in Serum or Plasma_observations', 'Thyroxine (T4) free [Mass/volume] in Serum or Plasma_observations', 'Tobacco smoking status NHIS_observations', 'Total Bilirubin (Elevated)_observations', 'Total Cholesterol_observations', 'Total score [MMSE]_observations', 'Treatment status Cancer_observations', 'Triglycerides_observations', 'Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method_observations', 'Tumor marker Cancer_observations', 'US Guidance for biopsy of Prostate_observations', 'Urea Nitrogen_observations', 'Urea nitrogen [Mass/volume] in Serum or Plasma_observations', 'VR-12 Bodily pain (BP) score - oblique method_observations', 'VR-12 General health (GH) score - oblique method_observations', 'VR-12 Mental health (MH) score - oblique method_observations', 'VR-12 Physical functioning (PF) score - oblique method_observations', 'VR-12 Role emotion (RE) score - oblique method_observations', 'VR-12 Role physical (RP) score - oblique method_observations', 'VR-12 Social functioning (SF) score - oblique method_observations', 'VR-12 Vitality (VT) score - oblique method_observations', 'WBC Auto (Bld) [#/Vol]_observations', 'Walnut IgE Ab in Serum_observations', 'Weight difference [Mass difference] --pre dialysis - post dialysis_observations', 'Weight-for-length Per age and sex_observations', 'Wheat IgE Ab in Serum_observations', 'White Blood Cell (Elevated)_observations', 'White oak IgE Ab in Serum_observations', 'pH of Arterial blood_observations', 'pH of Urine by Test strip_observations', 'Allergy to bee venom_allergies', 'Allergy to grass pollen_allergies', 'Allergy to tree pollen_allergies', 'Allergy to fish_allergies', 'Allergy to nut_allergies', 'Allergy to mould_allergies', 'Dander (animal) allergy_allergies', 'Shellfish allergy_allergies', 'House dust mite allergy_allergies', 'Allergy to dairy product_allergies', 'Allergy to eggs_allergies', 'Allergy to wheat_allergies', 'Latex allergy_allergies', 'Allergy to soya_allergies', 'Allergy to peanuts_allergies', 'Otitis media_conditions', 'Fever (finding)_conditions', 'Suspected COVID-19_conditions', 'COVID-19_conditions', 'Sprain of ankle_conditions', 'Cough (finding)_conditions', 'Sputum finding (finding)_conditions', 'Diarrhea symptom (finding)_conditions', 'Streptococcal sore throat (disorder)_conditions', 'Hypertension_conditions', 'Viral sinusitis (disorder)_conditions', 'Headache (finding)_conditions', 'Fatigue (finding)_conditions', 'Nausea (finding)_conditions', 'Vomiting symptom (finding)_conditions', 'Loss of taste (finding)_conditions', 'Nasal congestion (finding)_conditions', 'Dyspnea (finding)_conditions', 'Wheezing (finding)_conditions', 'Pneumonia (disorder)_conditions', 'Hypoxemia (disorder)_conditions', 'Respiratory distress (finding)_conditions', 'Acute pulmonary embolism (disorder)_conditions', 'Muscle pain (finding)_conditions', 'Joint pain (finding)_conditions', 'Body mass index 30+ - obesity (finding)_conditions', 'Prediabetes_conditions', 'Fracture of clavicle_conditions', 'Sore throat symptom (finding)_conditions', 'Brain damage - traumatic_conditions', 'Normal pregnancy_conditions', 'Miscarriage in first trimester_conditions', 'Anemia (disorder)_conditions', 'Stroke_conditions', 'Acute viral pharyngitis (disorder)_conditions', 'Perennial allergic rhinitis_conditions', 'Pulmonary emphysema (disorder)_conditions', 'Chronic sinusitis (disorder)_conditions', 'Coronary Heart Disease_conditions', 'Sepsis caused by virus (disorder)_conditions', 'Childhood asthma_conditions', 'Malignant neoplasm of breast (disorder)_conditions', 'Drug overdose_conditions', 'Cardiac Arrest_conditions', 'History of cardiac arrest (situation)_conditions', 'Osteoarthritis of knee_conditions', 'Perennial allergic rhinitis with seasonal variation_conditions', 'Osteoarthritis of hip_conditions', 'Hyperlipidemia_conditions', 'Atopic dermatitis_conditions', 'Seasonal allergic rhinitis_conditions', 'Chronic intractable migraine without aura_conditions', 'Recurrent urinary tract infection_conditions', 'Tubal pregnancy_conditions', 'Chill (finding)_conditions', 'Acute bronchitis (disorder)_conditions', 'Acute respiratory failure (disorder)_conditions', 'Septic shock (disorder)_conditions', 'Injury of kidney (disorder)_conditions', 'Injury of heart (disorder)_conditions', 'Heart failure (disorder)_conditions', 'Acute respiratory distress syndrome (disorder)_conditions', 'Diabetes_conditions', 'Hypertriglyceridemia (disorder)_conditions', 'Diabetic retinopathy associated with type II diabetes mellitus (disorder)_conditions', 'Hyperglycemia (disorder)_conditions', 'Metabolic syndrome X (disorder)_conditions', 'Nonproliferative diabetic retinopathy due to type 2 diabetes mellitus (disorder)_conditions', 'Impacted molars_conditions', 'Hemoptysis (finding)_conditions', 'Osteoporosis (disorder)_conditions', 'Seizure disorder_conditions', 'History of single seizure (situation)_conditions', 'Acute bacterial sinusitis (disorder)_conditions', 'Neuropathy due to type 2 diabetes mellitus (disorder)_conditions', 'Proliferative diabetic retinopathy due to type II diabetes mellitus (disorder)_conditions', 'Localized  primary osteoarthritis of the hand_conditions', 'Epilepsy_conditions', 'Atrial Fibrillation_conditions', 'Acquired coagulation disorder (disorder)_conditions', 'Polyp of colon_conditions', 'Recurrent rectal polyp_conditions', 'Acute deep venous thrombosis (disorder)_conditions', 'Preeclampsia_conditions', 'Laceration of thigh_conditions', 'Myocardial Infarction_conditions', 'History of myocardial infarction (situation)_conditions', 'Chronic congestive heart failure (disorder)_conditions', 'Fetus with unknown complication_conditions', 'Child attention deficit disorder_conditions', 'Suspected lung cancer (situation)_conditions', 'Small cell carcinoma of lung (disorder)_conditions', 'Primary small cell malignant neoplasm of lung  TNM stage 1 (disorder)_conditions', 'Concussion with loss of consciousness_conditions', 'Concussion with no loss of consciousness_conditions', 'Chronic kidney disease stage 1 (disorder)_conditions', 'Diabetic renal disease (disorder)_conditions', 'Chronic kidney disease stage 2 (disorder)_conditions', 'Microalbuminuria due to type 2 diabetes mellitus (disorder)_conditions', 'Chronic pain_conditions', 'Bacterial infectious disease (disorder)_conditions', 'Neoplasm of prostate_conditions', 'Carcinoma in situ of prostate (disorder)_conditions', 'Acute allergic reaction_conditions', \"Alzheimer's disease (disorder)_conditions\", 'Appendicitis_conditions', 'History of appendectomy_conditions', 'Chronic obstructive bronchitis (disorder)_conditions', 'Second degree burn_conditions', 'Body mass index 40+ - severely obese (finding)_conditions', 'Pneumonia_conditions', \"Familial Alzheimer's disease of early onset (disorder)_conditions\", 'Sinusitis (disorder)_conditions', 'Fracture of forearm_conditions', 'Rupture of appendix_conditions', 'Laceration of foot_conditions', 'Laceration of forearm_conditions', 'Fracture subluxation of wrist_conditions', 'Non-small cell lung cancer (disorder)_conditions', 'Non-small cell carcinoma of lung  TNM stage 1 (disorder)_conditions', 'Idiopathic atrophic hypothyroidism_conditions', 'Burn injury(morphologic abnormality)_conditions', 'Bleeding from anus_conditions', 'Protracted diarrhea_conditions', 'Sprain of wrist_conditions', 'Chronic paralysis due to lesion of spinal cord_conditions', 'Overlapping malignant neoplasm of colon_conditions', 'Malignant tumor of colon_conditions', 'Escherichia coli urinary tract infection_conditions', 'Gout_conditions', 'Pathological fracture due to osteoporosis (disorder)_conditions', 'Fracture of ankle_conditions', 'Whiplash injury to neck_conditions', 'Traumatic brain injury (disorder)_conditions', 'Fracture of rib_conditions', 'Alcoholism_conditions', 'Bullet wound_conditions', 'Smokes tobacco daily_conditions', 'Facial laceration_conditions', 'Injury of tendon of the rotator cuff of shoulder_conditions', 'Laceration of hand_conditions', 'Macular edema and retinopathy due to type 2 diabetes mellitus (disorder)_conditions', 'Asthma_conditions', 'Major depression disorder_conditions', 'Primary fibromyalgia syndrome_conditions', 'Metastasis from malignant tumor of prostate (disorder)_conditions', 'Cystitis_conditions', 'First degree burn_conditions', 'Opioid abuse (disorder)_conditions', 'Concussion injury of brain_conditions', 'Closed fracture of hip_conditions', 'Passive conjunctival congestion (finding)_conditions', 'Contact dermatitis_conditions', 'Injury of medial collateral ligament of knee_conditions', 'Rheumatoid arthritis_conditions', 'Primary malignant neoplasm of colon_conditions', 'At risk for suicide (finding)_conditions', 'Rupture of patellar tendon_conditions', 'Blighted ovum_conditions', 'Secondary malignant neoplasm of colon_conditions', 'Non-low risk pregnancy_conditions', 'History of amputation of foot (situation)_conditions', 'Fracture of the vertebral column with spinal cord injury_conditions', 'History of lower limb amputation (situation)_conditions', 'Antepartum eclampsia_conditions', 'Lupus erythematosus_conditions', 'Injury of anterior cruciate ligament_conditions', 'Chronic kidney disease stage 3 (disorder)_conditions', 'Proteinuria due to type 2 diabetes mellitus (disorder)_conditions', 'Third degree burn_conditions', 'Tear of meniscus of knee_conditions', 'Posttraumatic stress disorder_conditions', 'Female Infertility_conditions', 'Cystic Fibrosis_conditions', 'Diabetes from Cystic Fibrosis_conditions', 'Blindness due to type 2 diabetes mellitus (disorder)_conditions', 'History of disarticulation at wrist (situation)_conditions', 'Male Infertility_conditions', 'Acute Cholecystitis_conditions', 'Cholelithiasis_conditions', 'Influenza  seasonal  injectable  preservative free_immunizations', 'Hep A  ped/adol  2 dose_immunizations', 'meningococcal MCV4P_immunizations', 'Hep B  adolescent or pediatric_immunizations', 'Hib (PRP-OMP)_immunizations', 'rotavirus  monovalent_immunizations', 'IPV_immunizations', 'DTaP_immunizations', 'Pneumococcal conjugate PCV 13_immunizations', 'Td (adult) preservative free_immunizations', 'Hep A  adult_immunizations', 'varicella_immunizations', 'MMR_immunizations', 'zoster_immunizations', 'HPV  quadrivalent_immunizations', 'Hep B  adult_immunizations', 'Tdap_immunizations', 'pneumococcal polysaccharide vaccine  23 valent_immunizations']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Applying SMOTE: 100%|██████████| 1/1 [00:16<00:00, 16.82s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Highly correlated features with COVID-19_conditions: ['Body temperature_observations', 'Oxygen saturation in Arterial blood_observations', 'Suspected COVID-19_conditions', 'COVID-19_conditions']\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "# Load and merge the datasets\n",
    "merged_data = load_and_merge_data(file_paths)\n",
    "\n",
    "# Extract high correlation features\n",
    "with tqdm(total=1, desc=\"Applying SMOTE\") as pbar:\n",
    "    high_corr_features = extract_high_correlation_features(merged_data, target_column='COVID-19_conditions', threshold=0.8)\n",
    "    pbar.update(1)\n",
    "    \n",
    "print(\"Highly correlated features with COVID-19_conditions:\", high_corr_features)\n",
    "\n",
    "\n",
    "# Train and evaluate the model\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Applying SMOTE: 100%|██████████| 1/1 [00:01<00:00,  1.38s/it]\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 800x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\sagor\\AppData\\Local\\Programs\\Python\\Python311\\Lib\\site-packages\\keras\\src\\layers\\convolutional\\base_conv.py:107: UserWarning: Do not pass an `input_shape`/`input_dim` argument to a layer. When using Sequential models, prefer using an `Input(shape)` object as the first layer in the model instead.\n",
      "  super().__init__(activity_regularizer=activity_regularizer, **kwargs)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Epoch 1/3\n",
      "\u001b[1m677/677\u001b[0m \u001b[32m━━━━━━━━━━━━━━━━━━━━\u001b[0m\u001b[37m\u001b[0m \u001b[1m134s\u001b[0m 192ms/step - accuracy: 0.8924 - loss: 3.1560 - val_accuracy: 0.9647 - val_loss: 0.9104\n",
      "Epoch 2/3\n",
      "\u001b[1m677/677\u001b[0m \u001b[32m━━━━━━━━━━━━━━━━━━━━\u001b[0m\u001b[37m\u001b[0m \u001b[1m124s\u001b[0m 183ms/step - accuracy: 0.9354 - loss: 0.9068 - val_accuracy: 0.9586 - val_loss: 0.7744\n",
      "Epoch 3/3\n",
      "\u001b[1m677/677\u001b[0m \u001b[32m━━━━━━━━━━━━━━━━━━━━\u001b[0m\u001b[37m\u001b[0m \u001b[1m123s\u001b[0m 181ms/step - accuracy: 0.9403 - loss: 0.7601 - val_accuracy: 0.9701 - val_loss: 0.6278\n",
      "\u001b[1m212/212\u001b[0m \u001b[32m━━━━━━━━━━━━━━━━━━━━\u001b[0m\u001b[37m\u001b[0m \u001b[1m6s\u001b[0m 28ms/step - accuracy: 0.9682 - loss: 0.6367\n",
      "Test Loss: 0.6306197643280029, Test Accuracy: 0.9685423374176025\n",
      "\u001b[1m212/212\u001b[0m \u001b[32m━━━━━━━━━━━━━━━━━━━━\u001b[0m\u001b[37m\u001b[0m \u001b[1m4s\u001b[0m 19ms/step\n",
      "Classification Report:\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      0.99      1.00      1692\n",
      "           1       1.00      0.99      0.99      1672\n",
      "           2       0.98      0.91      0.94      1722\n",
      "           3       0.91      0.98      0.94      1685\n",
      "\n",
      "    accuracy                           0.97      6771\n",
      "   macro avg       0.97      0.97      0.97      6771\n",
      "weighted avg       0.97      0.97      0.97      6771\n",
      "\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x800 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[1m78/78\u001b[0m \u001b[32m━━━━━━━━━━━━━━━━━━━━\u001b[0m\u001b[37m\u001b[0m \u001b[1m1s\u001b[0m 16ms/step\n",
      "Original Test Set Classification Report:\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       0.99      0.99      0.99        74\n",
      "           1       0.99      0.99      0.99       387\n",
      "           2       0.88      0.84      0.86       297\n",
      "           3       0.97      0.98      0.98      1713\n",
      "\n",
      "    accuracy                           0.97      2471\n",
      "   macro avg       0.96      0.95      0.95      2471\n",
      "weighted avg       0.97      0.97      0.97      2471\n",
      "\n"
     ]
    }
   ],
   "source": [
    "\n",
    "# Train and evaluate the model\n",
    "trained_model = train_and_evaluate_model(merged_data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Label distribution: (array([0, 1, 2, 3]), array([  19, 2333, 3005, 6995]))\n",
      "(array([0, 1, 2, 3]), array([  19, 2333, 3005, 6995]))\n"
     ]
    }
   ],
   "source": [
    "\"\"\" labels = create_labels(merged_data)\n",
    "print(np.unique(labels, return_counts=True)) \"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rows with valid labels: 11771\n"
     ]
    }
   ],
   "source": [
    "\"\"\" filtered_data = merged_data[[\"DECEASED_patients\", \"COVID-19_conditions\"]].dropna()\n",
    "print(f\"Rows with valid labels: {len(filtered_data)}\")\n",
    " \"\"\""
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
